Health Insurance (Accredited Pathology Laboratories — Approval) Amendment Principles 2007 (No. 2) (Cth)

Case

Health Insurance (Accredited Pathology Laboratories — Approval) Amendment Principles 2007 (No. 2)

Health Insurance Act 1973

I, MEGAN PHILOMENA MORRIS, First Assistant Secretary, Medical Benefits Division, Department of Health and Ageing, determine these Principles under subsection 23DNA (1) of the Health Insurance Act 1973.

Dated 3 September 2007

MEGAN MORRIS

First Assistant Secretary, Medical Benefits Division,

Department of Health and Ageing


  1. Name of Principles

These Principles are the Health Insurance (Accredited Pathology Laboratories — Approval) Amendment Principles 2007 (No. 2).

  1. Commencement

These Principles commence on 1 January 2008.

  1. Amendment of Health Insurance (Accredited Pathology Laboratories — Approval) Principles 2002

Schedule 1 amends the Health Insurance (Accredited Pathology Laboratories — Approval) Principles 2002.


Schedule 1        Amendments

(section 3)

[1]           Section 3, note

substitute

Note   See also subsection 23DN (3) of the Act.

[2]           Section 5, note

substitute

Note 1   Several other words and expressions used in these Principles have the meaning given by section 3 of the Act. For example:

·      accredited pathology laboratory

·      approved pathology practitioner

·      pathology service

·      pathology services table.

Note 2   Several other words and expressions have the meaning given by section 23DNA of the Act. For example:

·      pathologist

·      scientist

·      senior scientist.

[3]           Section 14, note

substitute

Note   See also paragraph 23DN (2A) (c) of the Act.

[4]           Schedule 1

substitute

Schedule 1        Accreditation materials

(section 5)

Part 1          NPAAC materials

Item

Material

Publication year

1 Guidelines for Laboratory Procedures Related to the Processing, Storage and Infusion of Cells for Transplantation or Cell Therapy 2004
2 Guidelines for the Facilities and Operation of Hospital and Forensic Mortuaries 2004
3 Standards for Pathology Laboratory Participation in External Proficiency Testing Programs 2004
4 Guidelines for Approved Pathology Collection Centres 2006
5 Guidelines for the Performance of the Pathology Surgical Cut-up 2006
6 Guidelines for the use of Liquid Based Collection Systems and Semi-Automated Screening Devices in the Practice of Gynaecological (Cervical) Cytology 2006
7 Laboratory Accreditation Standards and Guidelines for Nucleic Acid Detection and Analysis 2006
8 Performance Measures for Australian Laboratories Reporting Cervical Cytology 2006
9 Requirements for Gynaecological (Cervical) Cytology 2006
10 Requirements for Supervision of Pathology Laboratories 2006
11 Standards and Guidelines for Laboratory Testing of Antibodies to the Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) 2006
12 Classification of Human Genetic Testing 2007
13 Requirements for Quality Management in Medical Laboratories 2007
14 Requirements for Cytogenetic Testing 2007
15 Requirements for Information Communication 2007
16 Requirements for the Packaging and Transport of Pathology Specimens and Associated Materials 2007
17 Requirements for Pathology Laboratories 2007
18 Requirements for the Development and Use of In-house In Vitro Diagnostic Devices (IVDs) 2007
19 Requirements for the Estimation of Measurement Uncertainty 2007
20 Requirements for the Retention of Laboratory Records and Diagnostic Material 2007

Note   The documents mentioned in Part 1 are available on the Internet — see 2          Other materials

1.       National Association of Testing Authorities NATA AS 4633 (ISO 15189) Application Document — Supplementary Requirements for Accreditation in the Field of Medical Testing, published in 2005.

Note   The document mentioned in item 1 is available from the National Association of Testing Authorities — see

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0